IL-4R alpha antagonist (Ventyx Biosciences)

N/A

Report date: 2025/03/20 15:24:41
NME

Base Information

Drug NameIL-4R alpha antagonist (Ventyx Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-4 receptors inhibitors
TargetsInterleukin-4 receptors
Therapy Area/IndicationsAutoimmune DiseasesDermatitis, AtopicAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVentyx Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVentyx Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDermatitis, AtopicAsthma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A